Genzyme withdraws offer for development partnership
This article was originally published in Clinica
Executive Summary
US biotechnology company Genzyme has withdrawn its offer to acquire, in a stock swap, all the assets of Genzyme Development Partners, also known as the Surgical Aids Partnership). Genzyme had offered to purchase the partnership in February for $93 million in Genzyme shares (see Clinica No 691, p 10).